Literature DB >> 16362635

Very long term studies of the seeding of beta-amyloidosis in primates.

R M Ridley1, H F Baker, C P Windle, R M Cummings.   

Abstract

Cerebral beta-amyloidosis was found in 16/18 marmosets aged <10 yrs and 8/9 marmosets aged >10 yrs, injected intracerebrally with human or marmoset brain homogenate containing beta-amyloid 1-8 years previously. It was found in only 2/12 marmosets aged <10 yrs and 1/15 marmosets aged >10 yrs, injected with synthetic Abeta-peptides, CSF, or brain tissue which did not contain beta-amyloid. Cerebral beta-amyloidosis was found in 0/11 uninjected marmosets aged <10 yrs and in 5/29 uninjected marmosets aged >10 yrs. The beta-amyloidosis comprised small and large vessel angiopathy and some plaques throughout cortex and was qualitatively similar in injected marmosets and, when present, in uninjected marmosets. Of those injected marmosets which were positive, the amount of beta-amyloidosis was unrelated to age or incubation times but the 3 injected marmosets without beta-amyloidosis had incubation times of <3.5 years. We conclude that beta-amyloid, or associated factors, can initiate or accelerate the process of cerebral amyloidosis in primates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362635     DOI: 10.1007/s00702-005-0385-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Tau mutations cause frontotemporal dementias.

Authors:  M Goedert; R A Crowther; M G Spillantini
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

Review 3.  Structural neurology: are seeds at the root of neuronal degeneration?

Authors:  P T Lansbury
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

4.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

5.  Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

Authors:  N Andreasen; L Minthon; P Davidsson; E Vanmechelen; H Vanderstichele; B Winblad; K Blennow
Journal:  Arch Neurol       Date:  2001-03

6.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

7.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

8.  Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease.

Authors:  M B Podlisny; D R Tolan; D J Selkoe
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

9.  Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.

Authors:  Jasmina B Mackic; James Bading; Jorge Ghiso; Larry Walker; Thomas Wisniewski; Blas Frangione; Berislav V Zlokovic
Journal:  Vascul Pharmacol       Date:  2002-06       Impact factor: 5.773

10.  Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.

Authors:  Cynthia A Lemere; Amy Beierschmitt; Melitza Iglesias; Edward T Spooner; Jeanne K Bloom; Jodi F Leverone; Jessica B Zheng; Timothy J Seabrook; Dora Louard; Diana Li; Dennis J Selkoe; Roberta M Palmour; Frank R Ervin
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more
  65 in total

Review 1.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

2.  Cell biology. A unifying role for prions in neurodegenerative diseases.

Authors:  Stanley B Prusiner
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

Review 3.  Structural basis of infectious and non-infectious amyloids.

Authors:  Ulrich Baxa
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 4.  β-Amyloid Prions and the Pathobiology of Alzheimer's Disease.

Authors:  Joel C Watts; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

5.  Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats.

Authors:  Rebecca F Rosen; Jason J Fritz; Jeromy Dooyema; Amarallys F Cintron; Tsuyoshi Hamaguchi; James J Lah; Harry LeVine; Mathias Jucker; Lary C Walker
Journal:  J Neurochem       Date:  2011-11-18       Impact factor: 5.372

6.  The marmoset as a model of aging and age-related diseases.

Authors:  Suzette D Tardif; Keith G Mansfield; Rama Ratnam; Corinna N Ross; Toni E Ziegler
Journal:  ILAR J       Date:  2011

Review 7.  Bioassays and Inactivation of Prions.

Authors:  Kurt Giles; Amanda L Woerman; David B Berry; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 8.  The activities of amyloids from a structural perspective.

Authors:  Roland Riek; David S Eisenberg
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

9.  Predicting regional neurodegeneration from the healthy brain functional connectome.

Authors:  Juan Zhou; Efstathios D Gennatas; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

10.  Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.

Authors:  Yvonne S Eisele; Tristan Bolmont; Mathias Heikenwalder; Franziska Langer; Laura H Jacobson; Zheng-Xin Yan; Klaus Roth; Adriano Aguzzi; Matthias Staufenbiel; Lary C Walker; Mathias Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.